Rapport Therapeutics, Inc. (RAPP) Revenue (2026)

Rapport Therapeutics (RAPP) posted quarterly Revenue of $20.0 million for Q1 2026.

Rapport Therapeutics, Inc. (RAPP) Revenue (2026) Analysis & Trends

Rapport Therapeutics has disclosed Revenue across 1 years of filings, most recently posting $20.0 million for Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 20.00 Mn